Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Baxter
Harvard Business School
Express Scripts
McKesson

Last Updated: October 17, 2019

DrugPatentWatch Database Preview

Macleods Pharms Ltd Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for MACLEODS PHARMS LTD, and what generic and branded alternatives to MACLEODS PHARMS LTD drugs are available?

MACLEODS PHARMS LTD has sixty-eight approved drugs.

There are twelve tentative approvals on MACLEODS PHARMS LTD drugs.

Summary for Macleods Pharms Ltd
US Patents:0
Tradenames:56
Ingredients:55
NDAs:68

Drugs and US Patents for Macleods Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Macleods Pharms Ltd ZOLMITRIPTAN zolmitriptan TABLET;ORAL 203772-002 Sep 30, 2015 AB RX No No   Start Trial   Start Trial
Macleods Pharms Ltd IRBESARTAN irbesartan TABLET;ORAL 202254-001 Oct 3, 2012 AB RX No No   Start Trial   Start Trial
Macleods Pharms Ltd RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 203146-001 Sep 19, 2014 AB RX No No   Start Trial   Start Trial
Macleods Pharms Ltd DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 201146-001 Aug 17, 2012 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
McKinsey
Dow
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.